RSV is a common and pervasive cause of severe acute respiratory illness in older adults with no vaccine currently available
The Bidar API manufacturing facility of Sai Life Sciences has been on a path of significant expansion with its production capacity growing from 200KL in 2017 to 450KL
At its meeting, the board also approved raising the company’s authorised share capital to Rs. 42.50 crores from Rs. 37.50 crores.
Coordinated and collaborative efforts will strongly contribute to the achievement of shared goals faster: Mandaviya
JADE DARE trial met co-primary and key secondary endpoints and demonstrated a safety profile consistent with previous studies for moderate to severe atopic dermatitis
The Visby Medical sexual health click test is the first instrument-free PCR test for the detection of chlamydia, gonorrhoea and trichomonas, with results available within 30 minutes, during the patient visit
In the last two years, Sai Life Sciences has made significant investments and progress in advancing its sustainability agenda as part of its organizational transformation initiative
The aim is to give a fillip to R&D in the health sector to face the Covid-19 challenge
The foundation has been working closely with the Kidwai Memorial Institute of Oncology on several projects since 2001
Surgeries for the replacement of hip and knee joints have become common, the ones for the replacement of jaw joints and the use of 3D printed custom-made joints are new
Subscribe To Our Newsletter & Stay Updated
